S. Sonnenberg

发表

Kinetics of G–CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte‐stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study

N. Kröger, A. Zander, H. Mollnau, 2004, Transfusion.

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma

N. Kröger, A. Zander, G. Ehninger, 2002, Annals of Hematology.

Stem cell mobilisation with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donors

N. Kröger, A. Zander, W. Krüger, 2002, Bone Marrow Transplantation.

In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors

N. Kröger, A. Zander, W. Krüger, 2002, Bone Marrow Transplantation.

Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia

N. Kröger, W. Fiedler, A. Zander, 2000, Bone Marrow Transplantation.

Stem Cell Transplantation in Acute Myeloid Leukemia after Conditioning with Busulfan, Cyclophosphamide and Different Dosages of Etoposide (VP-16)

N. Kröger, W. Fiedler, A. Zander, 2003 .

Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.

N. Kröger, A. Zander, W. Krüger, 2002, Bone marrow transplantation.

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma

N. Kröger, G. Ehninger, A. Hänel, 2002, Annals of Hematology.